8.6.01: Specialty Pharmaceuticals Issue
Eight analysts, two experts and top management from twenty-four sector firms examine the Specialty Pharmaceuticals sector in this special 134-page issue from The Wall Street Transcript.

    Online subscribers to the Healthcare sector also get
    Health Care Facilities Issue & Medical Technology Issue

  1. Specialty Pharmaceuticals - In an in-depth (12,700 words) Analyst Roundtable, Timothy Anderson, Analyst covering the Specialty Pharmaceuticals and Drug Delivery sectors at Prudential Securities, Erick Lucera, Analyst at CJS Capital Management, LLC, Ian Sanderson, Managing Director at SG Cowen, Richard Silver, Senior Vice President at Lehman Brothers and Jerry Treppel, Managing Director with Banc of America Securities LLC, examine the outlook for the sector including, niche areas, new drug launches and share specific stock recommendations.
  2. Drug Delivery Stocks - In an in-depth (4,000 words) Analyst Interview, Louis Webb, Jr., Principal with Dain Rauscher Wessels, examines the outlook for the sector and shares specific stock recommendations
  3. Intersecting with Specialty Pharmaceuticals - In an in-depth (3,300 words) Sponsor Interview, John Rhodes, Managing Partner for Pharmaceuticals and Life Sciences at Deloitte & Touche, reviews the pharmaceutical market and the issues affecting the sector.
  4. Executive Search for Pharmaceutical Companies - In an in-depth (2,800 words) Sponsor Interview, Robert Hennessy, Managing Director at Hennessy Group, examines the sector and the marketing for recruiting services.
  5. The TWST confidential Off-The-Record survey of management performance at seventeen sector firms asked market insiders about the ability of management teams to create shareholder value. Firms reviewed in Off-The-Record include:
    Alkermes, Allergan, Aradigm, Barr Laboratories, Cima Labs, Elan, Forest Laboratories, ICOS, Inhale Therapeutic Systems, IVAX, King Pharmaceuticals, KOS Pharmaceuticals, Medicis Pharmaceutical, Mylan Laboratories, Sepracor, SICOR, Teva Pharmaceutical Industries
  6. CEO interviews (average 2,500 words). Top management of twenty-four sector firms examine the outlook for their firm and the sector. Firms include:
    Cell Pathways, Ostex International, Questcor Pharmaceuticals, Veos Plc, Adolor, AnorMED, AP Pharma, BioReliance, BioSpecifics Technologies, Covalent Group, Delcath Systems, Flemington Pharmaceutical, Gentiva Health Services, Hemispherx BioPharma, Lorus Therapeutics, Meridian Medical Technologies, Nastech Pharmaceutical Company, Orphan Medical, Diversified Senior Services, Pain Therapeutics, Peregrine Pharmaceuticals, Sepracor, SIGA Technologies, Tender Loving Care Health Care Services
    7. ORDER THIS REPORT NOW! ONLY $175
    The report will be mailed first class. For fedex delivery, specify in the report details section and either include your fedex number or we will add $15 delivery charge. All sales are final.  Questions, call (212) 952-7433, or email us
    For immediate access online - click here to gain a password.
     
    Report details:  
    Your Name:  
    		 Company: 
    Address: 
    		 City: 
    State/Province:
    		 ZIP/Postal Code:
          		 Country:
    Phone:
    		 E-Mail:

    BILLING INFORMATION
    Credit Card
    		 Expiration Month/Year:
    Credit Card Number: 
     

     This Issue costs $175 - and is non-returnable.   

    The Wall Street Transcript does not endorse the views of any interviewee nor does it make stock recommendations.

     

Investors and Industry Execs.

The Wall Street Transcript has been used by investors and industry executives for 40 years as a unique tool for company and industry research.

TWST's roundtable panels and analyst interviews provide a sector perspective from Wall Street's best. 

Money manager interviews provide the view from the buy-side.

CEO interviews with hundreds of companies from the major sectors gives the company perspective right from the top.

Subscribe to a unique research tool for investors and industry executives. Call (212) 952 7433 or click here.

Sincerely,

Andrew Pickup
Publisher
HOME PRODUCTS SUBSCRIBE ABOUT ARCHIVE HOTLINE CONTACT EUROPE